(Q39381589)

11 September 2017

title

Patient preference in clinical trials for headache medication: the patient's view (English)

1 reference

11 September 2017

1 reference

Leinisch-Dahlke E

1

1 reference

11 September 2017

Akova-Oztürk E

2

1 reference

11 September 2017

Bertheau U

3

1 reference

11 September 2017

Isberner I

4

1 reference

11 September 2017

Evers S

5

1 reference

11 September 2017

May A

6

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

11 September 2017

1 reference

11 September 2017

volume

24

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

347-355

1 reference

Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Determinants of patient satisfaction with migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Treatment of migraine with rizatriptan: when to take the medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Patient treatment preferences and the 5-HT1B/1D agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Acute migraine treatment outcome measures: a clinician's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Assessing the efficacy of drugs for the acute treatment of migraine: issues in clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Alternative therapies in headache. Is there a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Assessing patient preference in migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

What do patients with migraine want from acute migraine treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Evaluation of migraineurs' preferences for naratriptan over conventional first-line agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Questioning placebo controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Bioethics. Helsinki's new clinical rules: fewer placebos, more disclosure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

What matters is not the differences between triptans, but the differences between patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Comparison of rizatriptan and other triptans on stringent measures of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Integrating the triptans into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

Triptans are all different

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00677.X

10.1111/J.1468-2982.2004.00677.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference